These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities. Randall LM; Amante FH; McSweeney KA; Zhou Y; Stanley AC; Haque A; Jones MK; Hill GR; Boyle GM; Engwerda CR Infect Immun; 2008 Jul; 76(7):3312-20. PubMed ID: 18474652 [TBL] [Abstract][Full Text] [Related]
11. Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice. Oakley MS; Majam V; Mahajan B; Gerald N; Anantharaman V; Ward JM; Faucette LJ; McCutchan TF; Zheng H; Terabe M; Berzofsky JA; Aravind L; Kumar S PLoS One; 2009 Aug; 4(8):e6793. PubMed ID: 19710907 [TBL] [Abstract][Full Text] [Related]
12. Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria. Keita Alassane S; Nicolau-Travers ML; Menard S; Andreoletti O; Cambus JP; Gaudre N; Wlodarczyk M; Blanchard N; Berry A; Abbes S; Colongo D; Faye B; Augereau JM; Lacroux C; Iriart X; Benoit-Vical F PLoS One; 2017; 12(7):e0181300. PubMed ID: 28742109 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA. Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013 [TBL] [Abstract][Full Text] [Related]
14. Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a ¹H NMR spectroscopy-based metabonomic study. Ghosh S; Sengupta A; Sharma S; Sonawat HM J Proteome Res; 2012 Oct; 11(10):4992-5004. PubMed ID: 22838963 [TBL] [Abstract][Full Text] [Related]
16. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Amani V; Boubou MI; Pied S; Marussig M; Walliker D; Mazier D; Rénia L Infect Immun; 1998 Sep; 66(9):4093-9. PubMed ID: 9712753 [TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Pamplona A; Ferreira A; Balla J; Jeney V; Balla G; Epiphanio S; Chora A; Rodrigues CD; Gregoire IP; Cunha-Rodrigues M; Portugal S; Soares MP; Mota MM Nat Med; 2007 Jun; 13(6):703-10. PubMed ID: 17496899 [TBL] [Abstract][Full Text] [Related]
18. Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content. Tiberti N; Latham SL; Bush S; Cohen A; Opoka RO; John CC; Juillard A; Grau GE; Combes V Sci Rep; 2016 Dec; 6():37871. PubMed ID: 27917875 [TBL] [Abstract][Full Text] [Related]
19. Testing the impact of a single nucleotide polymorphism in a Plasmodium berghei ApiAP2 transcription factor on experimental cerebral malaria in mice. Akkaya M; Bansal A; Sheehan PW; Pena M; Cimperman CK; Qi CF; Yazew T; Otto TD; Billker O; Miller LH; Pierce SK Sci Rep; 2020 Aug; 10(1):13630. PubMed ID: 32788672 [TBL] [Abstract][Full Text] [Related]
20. CD47 blockade reduces the pathologic features of experimental cerebral malaria and promotes survival of hosts with Torrez Dulgeroff LB; Oakley MS; Tal MC; Yiu YY; He JQ; Shoham M; Majam V; Okoth WA; Malla P; Kumar S; Weissman IL Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]